This report contains market size and forecasts of Streptomycin Sulfate API in global, including the following market information:
Global Streptomycin Sulfate API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Streptomycin Sulfate API Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Streptomycin Sulfate API companies in 2021 (%)
The global Streptomycin Sulfate API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Grade Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Streptomycin Sulfate API include Meiji Holdings, Sichuan Long March Pharmaceutical, Hebei Shengxue Dacheng Pharmaceutical and North China Pharmaceutical Huasheng, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Streptomycin Sulfate API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Streptomycin Sulfate API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Streptomycin Sulfate API Market Segment Percentages, by Type, 2021 (%)
Oral Grade
Injection Grade
Global Streptomycin Sulfate API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Streptomycin Sulfate API Market Segment Percentages, by Application, 2021 (%)
Human
Animal
Agriculture
Global Streptomycin Sulfate API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Streptomycin Sulfate API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Streptomycin Sulfate API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Streptomycin Sulfate API revenues share in global market, 2021 (%)
Key companies Streptomycin Sulfate API sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Streptomycin Sulfate API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Meiji Holdings
Sichuan Long March Pharmaceutical
Hebei Shengxue Dacheng Pharmaceutical
North China Pharmaceutical Huasheng